Correlation between urinary GAG and anti-idursulfase ERT neutralizing antibodies during treatment with NICIT immune tolerance regimen: A case report(,)

INTRODUCTION: Antibodies to intravenous idursulfase enzyme replacement therapy (ERT) for patients with Hunter syndrome (mucopolysaccharidosis type II, MPS II) can have a harmful clinical impact, including both increasing risk of infusion reactions and inhibiting therapeutic activity. Thus, failure t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sarah, Whitley, Chester B., Jarnes Utz, Jeanine R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5798249/
https://www.ncbi.nlm.nih.gov/pubmed/28610913
http://dx.doi.org/10.1016/j.ymgme.2017.06.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5798249/
https://www.ncbi.nlm.nih.gov/pubmed/28610913
http://dx.doi.org/10.1016/j.ymgme.2017.06.001

Ejemplares similares